ASSERTIO THERAPEUTICS, INC. Financing Cash Flow
ASSERTIO THERAPEUTICS, INC. reported Financing Cash Flow of -$360.11 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-05-11
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was -$360.11M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was -$19.97M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was -$54.29M, a 47720.18% decline year-over-year.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2019-06-30 was -$55.13M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2019 was -$157.84M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2018 was -$81.35M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2017 was -$110.89M.
- ASSERTIO THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2016 was -$100.17M, a 117.63% decline from fiscal 2015.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$360.11M 10-Q · filed 2020-05-11 | -$380.08M derived: sum of 2 quarters · filed 2020-05-11 | -$434.37M derived: sum of 3 quarters · filed 2020-05-11 | -$489.50M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-12-31 | -$19.97M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$74.26M derived: sum of 2 quarters · filed 2020-03-10 | -$129.40M derived: sum of 3 quarters · filed 2020-03-10 | -$157.84M 10-K · filed 2020-03-10 |
| 2019-09-30 | -$54.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$109.42M derived: sum of 2 quarters · filed 2019-11-07 | -$137.86M 10-Q · filed 2019-11-07 | -$163.06M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-06-30 | -$55.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$83.58M 10-Q · filed 2019-08-09 | -$108.77M derived: sum of 3 quarters · filed 2020-05-11 | -$108.66M derived: sum of 4 quarters · filed 2020-05-11 |
| 2019-03-31 | -$28.44M 10-Q · filed 2020-05-11 | -$53.64M derived: sum of 2 quarters · filed 2020-05-11 | -$53.52M derived: sum of 3 quarters · filed 2020-05-11 | -$110.15M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$25.20M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$25.08M derived: sum of 2 quarters · filed 2020-03-10 | -$81.71M derived: sum of 3 quarters · filed 2020-03-10 | -$81.35M 10-K · filed 2020-03-10 |
| 2018-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$56.51M derived: sum of 2 quarters · filed 2019-11-07 | -$56.15M 10-Q · filed 2019-11-07 | -$68.69M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-06-30 | -$56.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$56.27M 10-Q · filed 2019-08-09 | -$68.80M derived: sum of 3 quarters · filed 2020-03-10 | -$68.89M derived: sum of 4 quarters · filed 2020-03-10 |
| 2018-03-31 | $360.00K 10-Q · filed 2019-05-09 | -$12.17M derived: sum of 2 quarters · filed 2020-03-10 | -$12.27M derived: sum of 3 quarters · filed 2020-03-10 | -$112.21M derived: sum of 4 quarters · filed 2020-03-10 |
| 2017-12-31 | -$12.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$12.63M derived: sum of 2 quarters · filed 2020-03-10 | -$112.57M derived: sum of 3 quarters · filed 2020-03-10 | -$110.89M 10-K · filed 2020-03-10 |
| 2017-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$100.04M derived: sum of 2 quarters · filed 2018-11-09 | -$98.35M 10-Q · filed 2018-11-09 | -$99.01M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-06-30 | -$99.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$98.26M 10-Q · filed 2018-08-08 | -$98.91M derived: sum of 3 quarters · filed 2019-03-11 | -$97.63M derived: sum of 4 quarters · filed 2019-03-11 |
| 2017-03-31 | $1.68M 10-Q · filed 2018-05-10 | $1.03M derived: sum of 2 quarters · filed 2019-03-11 | $2.31M derived: sum of 3 quarters · filed 2019-03-11 | |
| 2016-12-31 | -$652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $630.00K derived: sum of 2 quarters · filed 2019-03-11 | -$100.17M 10-K · filed 2019-03-11 | |
| 2016-09-30 | $1.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$99.52M 10-Q · filed 2017-11-09 | ||
| 2016-06-30 | -$100.80M 10-Q · filed 2017-08-07 | |||
| 2015-12-31 | $568.10M 10-K · filed 2018-03-01 | |||
| 2013-03-31 | $408.00K 10-Q · filed 2013-05-09 | $1.21M derived: sum of 2 quarters · filed 2013-05-09 | $1.65M derived: sum of 3 quarters · filed 2013-05-09 | $2.63M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-12-31 | $801.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $1.25M derived: sum of 2 quarters · filed 2013-02-22 | $2.22M derived: sum of 3 quarters · filed 2013-02-22 | $2.69M 10-K · filed 2013-02-22 |
| 2012-09-30 | $444.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05 | $1.42M derived: sum of 2 quarters · filed 2012-11-05 | $1.89M 10-Q · filed 2012-11-05 | $2.31M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-06-30 | $973.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-13 | $1.44M 10-Q/A · filed 2012-08-13 | $1.87M derived: sum of 3 quarters · filed 2013-05-09 | $1.97M derived: sum of 4 quarters · filed 2013-05-09 |
| 2012-03-31 | $468.00K 10-Q · filed 2013-05-09 | $893.00K derived: sum of 2 quarters · filed 2013-05-09 | $999.00K derived: sum of 3 quarters · filed 2013-05-09 | $5.20M derived: sum of 4 quarters · filed 2013-05-09 |
| 2011-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $531.00K derived: sum of 2 quarters · filed 2013-02-22 | $4.73M derived: sum of 3 quarters · filed 2013-02-22 | $6.05M 10-K · filed 2013-02-22 |
| 2011-09-30 | $106.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05 | $4.30M derived: sum of 2 quarters · filed 2012-11-05 | $5.63M 10-Q · filed 2012-11-05 | $5.13M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-06-30 | $4.20M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-13 | $5.52M 10-Q/A · filed 2012-08-13 | $5.03M derived: sum of 3 quarters · filed 2013-02-22 | $4.37M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-03-31 | $1.32M 10-Q · filed 2012-05-08 | $828.00K derived: sum of 2 quarters · filed 2013-02-22 | $166.00K derived: sum of 3 quarters · filed 2013-02-22 | |
| 2010-12-31 | -$496.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -$1.16M derived: sum of 2 quarters · filed 2013-02-22 | -$2.43M 10-K · filed 2013-02-22 | |
| 2010-09-30 | -$662.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$1.93M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$1.27M 10-Q · filed 2011-08-02 | |||
| 2009-12-31 | -$1.27M 10-K · filed 2012-03-08 |